C07D 315/00
Heterocyclic compounds containing rings having one oxygen atom as the only ring
Official title: Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
C07D315/00 (Heterocyclic compounds containing rings having one oxygen atom as the only ring) appears on 344 US grants and 74 published applications in this corpus.
Search patents in C07D- Granted patents
- 344
- Published applications
- 74
- Assignees
- 170
- Inventors
- 710
- Latest grant
- 22 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 14 | 0 |
| 1978 | 11 | 0 |
| 1979 | 10 | 0 |
| 1980 | 9 | 0 |
| 1981 | 11 | 0 |
| 1982 | 15 | 0 |
| 1983 | 7 | 0 |
| 1984 | 7 | 0 |
| 1985 | 9 | 0 |
| 1986 | 12 | 0 |
| 1987 | 7 | 0 |
| 1988 | 9 | 0 |
| 1989 | 8 | 0 |
| 1990 | 12 | 0 |
| 1991 | 15 | 0 |
| 1992 | 11 | 0 |
| 1993 | 8 | 0 |
| 1994 | 13 | 0 |
| 1995 | 13 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 6 | 0 |
| 1999 | 11 | 0 |
| 2000 | 11 | 0 |
| 2001 | 15 | 5 |
| 2002 | 14 | 7 |
| 2003 | 8 | 7 |
| 2004 | 4 | 14 |
| 2005 | 7 | 7 |
| 2006 | 4 | 7 |
| 2007 | 6 | 6 |
| 2008 | 3 | 4 |
| 2009 | 5 | 1 |
| 2010 | 3 | 5 |
| 2011 | 3 | 1 |
| 2012 | 1 | 0 |
| 2013 | 3 | 2 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 2 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compound or salt thereof, composition, chemiluminescence method, method for measuring chemiluminescence signal, reagent, reagent kit, and method for assaying analyte22 Apr 2025US 12,281,092 B2Sysmex Corporation
- Vascular constructs11 Jun 2024US 12,006,592 B2Wake Forest University Health Sciences
- Vascular constructs8 Jun 2021US 11,028,502 B2Wake Forest University Health Sciences
- Malodor counteracting compositions and method for their use14 Jul 2020US 10,709,804 B2Firmenich SA
- Method and intermediate for preparing tulathromycin17 Sep 2019US 10,414,746 B2Zhejiang Hisun Pharmaceutical Co., Ltd.
- Vascular Constructs8 Jan 2026US 2026/0009164 A1Wake Forest University Health Sciences
- Compound or salt thereof, composition, chemiluminescence method, method for measuring chemiluminescence signal, reagent, reagent kit, and method for assaying analyte3 Aug 2023US 2023/0242499 A1Sysmex Corporation
- Vascular constructs2 Sep 2021US 2021/0269943 A1Wake Forest University Health Sciences
- Vascular Constructs2 May 2019US 2019/0127884 A1Wake Forest University Health Sciences
- Method and intermediate for preparing tulathromycin24 Jan 2019US 2019/0023681 A1Zhejiang Hisun Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Method for producing alcohols by hydrogenation of carbonyl compounds147US 6,486,366 B1Degussa AG · 2002
- Manufacture of butanediol and/or tetrahydrofuran from maleic and/or succinic anhydride via .gamma.- butyrolactone97US 4,048,196 ABASF SE · 1977
- Preparation of 5-membered ring heterocycles70US 5,453,516 ABASF SE · 1995
- Catalytic carbonylation of three and four membered heterocycles68US 6,852,865 B2Cornell Research Foundation, Inc. · 2005